Clinical Trial Update: Eisenmenger Quality Enhancement Research Initiative

View source ↗

Summary

The Eisenmenger Quality Enhancement Research Initiative trial sponsored by Actelion in pulmonary arterial hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Status: COMPLETED